RKIP has also been associated with advanced clinical stages, poor prognosis, and radio-resistant phenotypes in NPC cells [83], pointing to the potential use of RKIP as a biomarker for NPC prognosis. This evidence concerns the gene PEBP1 and nasopharyngeal carcinoma.